ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,520.90
0.32%
S&P ASX All Technology
3,990.90
1.23%
Brent Oil
76.375
0.43%
US Dollar vs AUD
1.60739
-0.08%
Bitcoin
104,298.18
-0.42%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Acticor Biotech (ALACT) Share Price

Acticor Biotech

Acticor Biotech (ALACT)

EU
0.25
0.00
(0.00%)
Closed 31 January 3:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.25
Bid
0.25
Offer
0.09
Volume
0.00
0.00 Day's Range 0.00
0.22 52 Week Range 5.30
Market Cap
3.939M
Previous Close
0.25
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
7,515
Shares Outstanding
15,755,227
Dividend Yield
-
PE Ratio
-0.21
Earnings Per Share (EPS)
-1.18
Revenue
2.63M
Net Profit
-18.64M

About Acticor Biotech

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.acticor-biotech.com
Headquarters
Paris, Paris, Fra
Founded
-
Acticor Biotech is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALACT. The last closing price for Acticor Biotech was 0.25 €. Over the last year, Acticor Biotech shares have traded in a share price range of 0.22 € to 5.30 €.

Acticor Biotech currently has 15,755,227 shares in issue. The market capitalisation of Acticor Biotech is 3.94 € million. Acticor Biotech has a price to earnings ratio (PE ratio) of -0.21.

Ask ADVFN Intelligence (AI)

ALACT Latest News

More News

Acticor Biotech announces its liquidation proceedings

Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...

06 January 2025
Business Wire

Acticor Biotech Announces that the Court Judgment Has Been Postponed Until January 2, 2025

Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...

20 December 2024
Business Wire

Acticor Biotech Announces the Filing of a Request for Conversion of Receivership Proceedings Into Liquidation Proceedings

Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...

11 December 2024
Business Wire

Acticor Biotech Provides an Update on the Current Receivership Proceedings

Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...

06 November 2024
Business Wire

CORRECTING and REPLACING: Acticor Biotech Publishes Its Half-year Financial Results for 2024

Regulatory News: This replaces the announcement made at 17:45 on October 31 because the following statement has been deleted: “The limited review procedures for the interim financial statements...

04 November 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.250.250.2500DE
4000.250.250.2500DE
12-0.16-39.02439024390.410.4390.2375150.31664873DE
26-0.224-47.25738396620.4740.890.22306230.52323396DE
52-4.2-94.38202247194.455.30.22511620.89178334DE
156-5.55-95.68965517245.8110.22192241.51382142DE
2600.07643.67816091950.174110.142598751.25188536DE

ALACT - Frequently Asked Questions (FAQ)

What is the current Acticor Biotech share price?
The current share price of Acticor Biotech is 0.25 €
How many Acticor Biotech shares are in issue?
Acticor Biotech has 15,755,227 shares in issue
What is the market cap of Acticor Biotech?
The market capitalisation of Acticor Biotech is EUR 3.94M
What is the 1 year trading range for Acticor Biotech share price?
Acticor Biotech has traded in the range of 0.22 € to 5.30 € during the past year
What is the PE ratio of Acticor Biotech?
The price to earnings ratio of Acticor Biotech is -0.21
What is the cash to sales ratio of Acticor Biotech?
The cash to sales ratio of Acticor Biotech is 1.5
What is the reporting currency for Acticor Biotech?
Acticor Biotech reports financial results in EUR
What is the latest annual turnover for Acticor Biotech?
The latest annual turnover of Acticor Biotech is EUR 2.63M
What is the latest annual profit for Acticor Biotech?
The latest annual profit of Acticor Biotech is EUR -18.64M
What is the registered address of Acticor Biotech?
The registered address for Acticor Biotech is WOJO BUILDING 82 AVENUE DU MAINE, PARIS, PARIS, 75014
What is the Acticor Biotech website address?
The website address for Acticor Biotech is www.acticor-biotech.com
Which industry sector does Acticor Biotech operate in?
Acticor Biotech operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BIODSBiosynex DS
0.0502 €
(80.58%)
96.34k
ALTROTronic s Microsystems
5.30 €
(35.20%)
5
MLWEYWeya
0.027 €
(35.00%)
99k
VACBSPierre & Vacances
0.0708 €
(24.21%)
46.14k
MCPGrupo Media Capital Sgps Sa
2.00 €
(23.46%)
1,000
MLGEQGentlemen S Equity SA
0.0115 €
(-47.73%)
6.2k
NICBSNicox SA
0.0183 €
(-30.68%)
140
AELISAelis Farma SA
3.76 €
(-21.67%)
33.01k
ALNEVNeovacs
0.32 €
(-17.40%)
21.49k
ALBOOBOOSTHEAT
0.035 €
(-16.27%)
43.42k
ATOAtos SE
0.0022 €
(4.76%)
1.58B
BCPBanco Comercial Portugues SA
0.5052 €
(-0.67%)
50M
ALNRGEnergisme SA
0.0041 €
(-6.82%)
29.28M
KPNKoninklijke KPN NV
3.554 €
(-1.88%)
12.28M
ALCYBCybergun
0.0001 €
(0.00%)
9.42M

Discussion

View Full Feed
Juststoppingby Juststoppingby 1 minute ago
There were 35 shares sold yesterday and 3 trades today, totaling 35,000 today.
https://investorshub.advfn.com/uimage/uploads/2025/1/30/ynmgkScreenshot_30-1-2025_81635_www.otcmarkets.com.jpeg
https://investorshub.advfn.com/uimage/uploads/2025/1/30/zbyfxScreenshot_30-1-2025_20304_www.otc
CRTG
Oleblue Oleblue 3 minutes ago
DeepSeek vs. ChatGPT

https://youtu.be/LXfeG8cEbmc
NVDA
sluggercjb sluggercjb 4 minutes ago
It’s ok i’d like to buy more at a sale price $$$ 👍🙂
RDGL
ProfitChaser ProfitChaser 5 minutes ago
Holding that 52wk high of .115 for 2 days now.
pos_stock_hoarder pos_stock_hoarder 7 minutes ago
Awesome roll there Getmore!
gfp927z gfp927z 8 minutes ago
Drama Queen Don - >>> Markets (and the world) on edge as Trump’s tariff deadline approaches


Yahoo Finance

by Ben Werschkul

January 30, 2025


https://finance.yahoo.com/news/markets-and-the-world-on-edge-as-trumps-tariff-deadl
Top Penny Top Penny 8 minutes ago
People say Pink Sheets are a losing battle and I always tell them tell that to Cromwell Coulsen, he did so well trading Pinks he ended up buying OTC Markets and made it what it is today, here is the man himself.....

https://investorshub.advfn.com/uimage/uploads/2018/1/19/edowmWPN-1550
IMG
Toofuzzy Toofuzzy 8 minutes ago
I haven't had many AIM.trades with the market drop and recovering as many of my holdings just stayed in my hold zone.

But I got to sell 8% of my holdings of WPM today at $63.

I'm glad to sell even if it moves higher as it has become 25% of my total assets with the help
€LL-$G7$ €LL-$G7$ 8 minutes ago
This POS still sitting and always will be in the gutter. Only ppl making money is the family dummies 
PSHG
ignatiusrielly35 ignatiusrielly35 9 minutes ago
This will cause a flurry of texts between the Fraudstein operatives and their minions. Look for a lot of EBZ/Mike the Fake Disgruntled Shareholder posts tomorrow. 
AVXL
pos_stock_hoarder pos_stock_hoarder 10 minutes ago
Major bummer bro!!!!
3331 3331 10 minutes ago
BIEL: BUYOUT/MERGER?
Sree Koneru, PhD's appointment to the Board of Directors at BioElectronics Corporation is a strategic move that will likely contribute to the company's growth and innovation in the medical technology sector.

Dr. Koneru is currently Director of Program Manag
Top Penny Top Penny 11 minutes ago
$PSRU on the launch pad!!!

https://investorshub.advfn.com/uimage/uploads/2019/2/26/rn[btgiphy.gif
PSRU
3331 3331 12 minutes ago
BIEL + DR. OZ + RFK = $$$
BIOELECTRONICS FLAGSHIP PRODUCT - ACTIPATCH - ON DR. OZ:
Dr. Oz devoted a whole program to explaining PEMF Pulsed ElectroMagnetic Field technology - with audience members wearing Actipatches (BIEL's flagship product) - saying it is changing the practice of med
3331 3331 12 minutes ago
BIEL + DR. OZ + RFK = $$$
BIOELECTRONICS FLAGSHIP PRODUCT - ACTIPATCH - ON DR. OZ:
Dr. Oz devoted a whole program to explaining PEMF Pulsed ElectroMagnetic Field technology - with audience members wearing Actipatches (BIEL's flagship product) - saying it is changing the practice of med
Researchfyi Researchfyi 13 minutes ago
Is that it? I’m very disappointed. I expected more. Hope you feel better, get well soon.
LQMT
konshe konshe 14 minutes ago
Stupid CEO if you want to sell shares, why not let PPS up then you can sell shares at higher PPS to get more cash??
CBDL

Your Recent History

EU
ALACT
Acticor Biotech
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads